FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new compound of 2-[3-(2,2-difluorobenzo[1,3]dioxol-5-ylamino)-5-(2,6-dimethylpyridin-4-yl)-[1,2,4]triazol4-yl]-N-ethylacetamide and/or pharmaceutically acceptable salts, or hydrate, or solvates, as well as to a method for preparing it; a pharmaceutical composition based on this compound and using its in therapy for prevention and treatment of mental disorders, intellectual disorders or diseases, inflammatory diseases or conditions wherein α7 nicotinic receptor modulation is considered to be favourable. The invention also refers to a product containing such compound and α7-nicotinic receptor agonist.
EFFECT: preparing the compounds applicable in therapy for prevention or treatment of mental disorders, intellectual disorders or diseases, inflammatory diseases or conditions wherein α7 nicotinic receptor modulation is considered to be favourable.
6 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRISUBSTITUTED 1,2,4-TRIAZOLES | 2008 |
|
RU2474579C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING POSITIVE MODULATOR OF NICOTINE RECEPTOR AGONIST AND AGONIST OF NICOTINE RECEPTOR, METHOD FOR TREATMENT | 1999 |
|
RU2225203C2 |
| ORGANIC COMPOUNDS | 2012 |
|
RU2610094C2 |
| AMIDES OF DIAZABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINE RECEPTORS AND PHARMACEUTIC COMPOSITION AND METHODS OF TREATMENT WITH THEIR APPLICATION | 2007 |
|
RU2448969C2 |
| NEURODEGENERATIVE DISORDERS | 2015 |
|
RU2707191C2 |
| DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USING THEM | 2010 |
|
RU2549551C2 |
| AMIDES OF DIASABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINIC RECEPTORS | 2007 |
|
RU2517693C2 |
| 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
| NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
| RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES | 2008 |
|
RU2417984C1 |
